Reports for HYDROCHLOROTHIAZIDE

Ingredient

HYDROCHLOROTHIAZIDE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
JAMP CANDESARTAN-HCT 12.5MG 32MG TABLET Actual shortage 2023-11-28 2024-04-17 211771
JAMP CANDESARTAN-HCT 25MG 32MG TABLET Actual shortage 2023-11-28 2024-04-17 211774
JAMP CANDESARTAN-HCT 25MG 32MG TABLET Actual shortage 2023-11-28 2024-04-17 211777
JAMP TELMISARTAN-HCT 12.5MG 80MG TABLET Actual shortage 2023-11-29 2024-03-19 211813
JAMP TELMISARTAN-HCT 12.5MG 80MG TABLET Actual shortage 2023-11-29 2024-04-15 211816
JAMP TELMISARTAN-HCT 25MG 80MG TABLET Actual shortage 2023-11-29 2024-03-30 211810
JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE 12.5MG 150MG TABLET Resolved 2017-03-27 2017-09-27 4437
JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE 12.5MG 150MG TABLET Actual shortage 2019-10-11 2021-04-05 96180
JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE 150MG 12.5MG TABLET Actual shortage 2021-04-07 2021-04-07 137069
JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE 12.5MG 300MG TABLET Resolved 2017-03-27 2017-09-27 4430

Showing 261 to 270 of 670

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-CANDESARTAN/HCTZ 25MG 32MG TABLET Discontinued 2018-02-26 2018-05-03 41011
APO-CANDESARTAN/HCTZ 12.5MG 32MG TABLET Discontinued 2018-02-26 2018-02-26 41020
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-02-26 2018-02-26 41047
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-09-07 2018-09-15 60331
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-09-07 2018-09-15 60335
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-02-23 40757
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-07-17 40760
APO-IRBESARTAN/HCTZ Discontinued 2018-02-23 2018-07-17 40763
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40766
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40769

Showing 21 to 30 of 102